Order Article Reprints

Otte K, Zhao K, Braun M, Neubauer A, Raifer H, Helmprobst F, Barrera FO, Nimsky C, Bartsch JW, Rusch T. Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide. Biomedicines. 2022; 10(9):2145. https://doi.org/10.3390/biomedicines10092145

Otte, Katharina, Kai Zhao, Madita Braun, Andreas Neubauer, Hartmann Raifer, Frederik Helmprobst, Felipe Ovalle Barrera, Christopher Nimsky, Jörg W. Bartsch, and Tillmann Rusch. 2022. "Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide" Biomedicines 10, no. 9: 2145. https://doi.org/10.3390/biomedicines10092145

Otte, K., Zhao, K., Braun, M., Neubauer, A., Raifer, H., Helmprobst, F., Barrera, F. O., Nimsky, C., Bartsch, J. W., & Rusch, T. (2022). Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide. Biomedicines, 10(9), 2145. https://doi.org/10.3390/biomedicines10092145